US Drug Recall Register
Class II · Moderate risk Ongoing Initiated May 29, 2013 (13 years ago)

Furosemide 50 mg/ml Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

What was recalled

Furosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Recalling firm
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-730-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Furosemide recalls

See all
Class II · Moderate risk Ongoing

Furosemide Tablets

Reason CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Leading Pharma, LLC NDC 69315-118-01 D-0486-2026
Class II · Moderate risk Ongoing

Furosemide Tablets

Reason Presence of Foreign Substance

Graviti Pharmaceuticals Private Limited NDC 64980-563-10 D-0293-2026
Class II · Moderate risk Terminated

Furosemide Tablets USP

Reason Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.

Roxane Laboratories, Inc. NDC 0054-4297-31 D-0437-2017
Class II · Moderate risk Terminated

Furosemide 20 mg/mL svn Sol

Reason Lack of Assurance of Sterility

Western Drug D-0405-2016